Full-Time

Director – Finance Business Systems

Posted on 11/21/2024

Vaxcyte

Vaxcyte

201-500 employees

Develops vaccines for bacterial infections

Biotechnology
Healthcare

Compensation Overview

$232k - $241kAnnually

Senior, Expert

San Carlos, CA, USA

Requires onsite presence in San Carlos, California for three days per week.

Category
Corporate Finance
Financial Planning and Analysis (FP&A)
Finance & Banking
Required Skills
NetSuite
SAP Products
Oracle
Requirements
  • Bachelor’s degree in Computer Science, Information Technology, Business Administration, or a related field, with 12+ years of experience in Finance and Accounting systems and software.
  • Experience implementing, designing, maintaining and enhancing ERP and related financial systems & tools, is required.
  • Strong knowledge of internal controls/SOX and financial reporting systems framework in a public company setting is required.
  • Proven experience in developing and executing Finance-related technology strategies that drive business growth and efficiency.
  • Working knowledge of security best practices (e.g., segregation of duties) for Finance-related systems.
  • Experience in fast-paced environment, highly driven with the ability to conduct multiple tasks and meet deadlines.
  • Outstanding organizational, problem-solving, and analytical skills.
  • Demonstrated ability to plan and organize projects, especially long-term.
  • Able to manage multiple complex projects and deliver in a timely manner.
  • Effectively communicates and presents information to senior management and other stakeholders (written, orally and via presentation materials), possesses an inquisitive mind, and works effectively with multiple functions; brings strong executive presence and the ability to influence decision making.
  • The ideal candidate will be a results-driven team player and must thrive in a fast-paced, dynamic environment. He/ She must have the ability to drive results, possesses a strong drive to meet and exceed goals and is willing to take ownership of problems and make or recommend sound decisions.
  • Ability to work onsite 3 days per week required; and more often based on business needs.
  • Embodies Vaxcyte’s cultural attributes: caring, courage, excellence and passion.
Responsibilities
  • Serve as Business System Lead for Finance’s technology portfolio. Provide business system admin support where needed. Partner closely with IT System Lead(s) to maintain, evolve, and introduce new Finance-related technologies.
  • Develop and execute on the company’s finance technology strategy in alignment with business goals and objectives.
  • Assist IT in preparation and ongoing updates of multi-year technology roadmap for Finance-related systems.
  • Collaborate closely with Finance teams, Supply Chain and Operations, People, IT and other support functions to build a world class technology footprint to enable efficiency at scale and to allow for the finance organization and the company to achieve its operating objectives.
  • Oversee the design, implementation, and maintenance of technology solutions, including but not limited to the selection and deployment of an Enterprise Resource Planning (ERP) system, to support business processes and operations. Current systems include, but are not limited to, Netsuite, Concur, Equity Edge, Anaplan, Workday, etc. and prospective systems may include SAP, Oracle among others.
  • Partner closely with IT to provide expertise, techno-functional support, administration, project management and maintenance of all internal finance and accounting systems.
  • Exercise judgment in selecting methods, techniques and evaluation criteria for obtaining optimal results.
  • Other special projects and assignments as required.

Vaxcyte develops vaccines aimed at preventing bacterial infections, focusing on diseases like invasive pneumococcal disease, Group A Strep, periodontitis, and Shigella. Their lead product, VAX-24, is a pneumococcal conjugate vaccine that targets 24 strains of the Streptococcus pneumoniae bacteria and has received Breakthrough Therapy designation from the FDA for adult use. Vaxcyte employs advanced chemistry and a proprietary cell-free protein synthesis platform, XpressCF™, to create vaccines that can effectively address the complex defenses of bacteria while eliciting a strong immune response. Unlike traditional cell-based methods, their approach allows for the development of broad-spectrum vaccines. Vaxcyte's goal is to provide effective vaccines that can significantly reduce the impact of bacterial infections on global health.

Company Stage

IPO

Total Funding

$273.3M

Headquarters

Foster City, California

Founded

2013

Growth & Insights
Headcount

6 month growth

23%

1 year growth

61%

2 year growth

132%
Simplify Jobs

Simplify's Take

What believers are saying

  • Significant investments from major financial entities like Vanguard and Mutual of America Capital Management indicate strong market confidence in Vaxcyte's potential.
  • The recent $816.5 million raised through stock and warrant sales provides substantial capital for advancing their vaccine pipeline.
  • The appointment of experienced board members like John Furey can provide strategic guidance and enhance corporate governance.

What critics are saying

  • The success of Vaxcyte heavily depends on the clinical and commercial success of its lead product, VAX-24, which is still subject to regulatory approval.
  • The competitive landscape in vaccine development is intense, with numerous established players potentially overshadowing Vaxcyte's market entry.

What makes Vaxcyte unique

  • Vaxcyte leverages its proprietary XpressCF™ cell-free protein synthesis platform, which allows for more efficient and versatile vaccine production compared to traditional cell-based methods.
  • Their focus on broad-spectrum vaccines, such as VAX-24 targeting 24 strains of Streptococcus pneumoniae, sets them apart in the vaccine development landscape.
  • The FDA Breakthrough Therapy designation for VAX-24 underscores the innovative potential and clinical significance of their lead product.

Help us improve and share your feedback! Did you find this helpful?